FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
SZCE:002252

Shanghai RAAS Blood Products Co., Ltd. Stock Insider Trading

Shenzhen Stock Exchange > Healthcare > Biotechnology
Open Broker Account
¥7.10
-0.0600 (-0.84%)
At Close: May 31, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood produ... 002252.SZ Profile

Golden Star

Ticker Date Change Price
OXM May 29 3.64% $106.80
UTZ May 29 2.43% $18.10
DVAX May 29 3.99% $11.53
GNTX May 28 1.66% $34.43
OHI May 20 4.76% $30.86
CNI May 16 0.600% $126.57
TTWO May 16 9.78% $146.08
RL May 15 11.92% $166.98
LNG May 14 0.235% $157.42
VCLT May 14 0.277% $75.73
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT